JacqueL.DuncanMDFARVO
Ophthalmology • San Francisco, CARetinal Disease
Chair and Professor, Ophthalmology, UCSF School of Medicine
Dr. Duncan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
490 Illinois St
4th floor
San Francisco, CA 94158Phone+1 415-353-2020Fax+1 415-353-2713
Summary
- Dr. Jacque Duncan is an ophthalmologist in San Francisco, CA and is affiliated with multiple hospitals in the area, including UCSF Medical Center, Zuckerberg San Francisco General Hospital and Trauma Center, and San Francisco VA Medical Center. She received her medical degree from University of California San Francisco School of Medicine and has been in practice 22 years.
Education & Training
Perelman School of Medicine at the University of PennsylvaniaMedical Retina Fellowship, Inherited Retinal Degeneration , Heed Ophthalmic Fellow, 1999 - 2000
University of California (San Francisco)Residency, Ophthalmology, 1996 - 1999- University of California (San Francisco)Internship, Internal Medicine, 1995 - 1996
- University of California San Francisco School of MedicineClass of 1995
Stanford UniversityBachelor of Science, Biological Sciences, Phi Beta Kappa, Honors and Distinction, 1986 - 1990
Certifications & Licensure
CA State Medical License 1996 - 2026
PA State Medical License 1999 - 2000- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Gold Fellow ARVO, 2022
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Retinal Imaging in Patients With Inherited Retinal Degenerations Start of enrollment: 2005 Nov 01
- Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa Start of enrollment: 2012 Jan 01
- Rate of Progression in USH2A-related Retinal Degeneration Start of enrollment: 2017 Aug 11
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsCol4a1 mutations cause progressive retinal neovascular defects and retinopathy.Marcel V. Alavi, Mao Mao, Bradley Pawlikowski, Manana Kvezereli, Jacque L. Duncan
Scientific Reports. 2016-01-27 - 62 citationsAdvancing Clinical Trials for Inherited Retinal Diseases: Recommendations from the Second Monaciano SymposiumDebra A. Thompson, Alessandro Iannaccone, Robin R. Ali, Vadim Y. Arshavsky, Isabelle Audo
Translational Vision Science & Technology. 2020-06-03 - 7 citationsChoriocapillaris Changes in Myopic Macular Degeneration.Jonathan Li, Hao Zhou, Max Feinstein, Jessica Wong, Ruikang K Wang
Translational Vision Science & Technology. 2022-02-01
Press Mentions
Clinical Challenges: Trials for Inherited Retinal DiseasesJuly 7th, 2022
Apprentice House Publishes Retina BoyNovember 5th, 2019
Doctors See Bright Future for Augmented SightMay 18th, 2019- Join now to see all
Grant Support
- Therapy For Dominantly Inherited Retinal DegenerationsNational Eye Institute2000–2004
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
